Absence of calretinin protein expression in malignant mesotheliomas from asbestos-exposed NF2+/− mice and mouse mesothelioma cell lines from various mouse strains by Blum, Walter et al.
SHORT REPORT Open Access
Absence of calretinin protein expression in
malignant mesotheliomas from asbestos-
exposed NF2+/− mice and mouse
mesothelioma cell lines from various
mouse strains
Walter Blum1, Thomas Henzi1, Hugues-Etienne Châtel-Soulet1, Laszlo Pecze1, Janine Wörthmüller Rodriguez1,
Bart Vrugt2 and Beat Schwaller1*
Abstract
Background: Calretinin is the most widespread positive marker for the immunohistochemical identification of
malignant mesothelioma (MM) and was proposed to serve as a blood-based biomarker. Functionally, evidence has
accumulated that calretinin might be implicated in MM tumorigenesis. We aimed to identify calretinin (CR; Calb2) in
murine MM and reactive mesothelial cells in granuloma from asbestos-exposed NF2+/− mice, a line heterozygous
for the tumor suppressor merlin (NF2), used as a mouse MM model. Additionally, we sought to ascertain the presence
of calretinin in MM cell lines from other mouse strains. We also intended to investigate the role of calretinin in
mesotheliomagenesis by comparing the survival of asbestos-exposed NF2+/− and NF2+/-CR−/− mice.
Methods: NF2+/− and NF2+/-CR−/− mice, both lines on a C57Bl/6J background, were exposed to asbestos following an
established protocol. Tumor histology and asbestos-induced mortality were assessed. MM and granuloma from NF2+/−
mice were analyzed with immunohistochemical methods for calretinin expression. Levels of Calb2 mRNA and calretinin
expression in tumors and MM cell lines of various mouse strains were determined by RT-qPCR and Western blot
analysis, respectively.
Results: No expression of calretinin at the protein level was detected, neither in MM from NF2+/− mice, NF2+/− MM-
derived cell lines nor immortalized mesothelial cells of mouse origin. At the mRNA level we detected Calb2 expression
in MM cell lines from different mouse strains. Survival of NF2+/− and NF2+/-CR−/− mice exposed to asbestos showed no
significant difference in a log-rank (Kaplan-Meier) comparison.
Conclusions: The concomitant determination of calretinin and mesothelin blood levels has been proposed for early
detection of human MM. Mouse MM models based on asbestos exposure are assumed to yield helpful information on
the time course of appearance of mesothelin and calretinin in the blood of asbestos-treated mice determining the
earliest time point for interventions. However, the observed absence of calretinin in MM from NF2+/− mice
and derived cell lines, as well as from MM cells from Balb/c and C3H mice likely precludes the use of calretinin as a
biomarker for mouse MM. The results also indicate possible species differences with respect to an involvement
of calretinin in the formation of MM.
Keywords: Malignant mesothelioma, Calretinin, Calb2, C57Bl/6J, NF2+/− mice, Asbestos
* Correspondence: beat.schwaller@unifr.ch
1Anatomy, Section of Medicine, University of Fribourg, Route Albert-Gockel 1,
CH-1700 Fribourg, Switzerland
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Blum et al. Biomarker Research  (2018) 6:19 
https://doi.org/10.1186/s40364-018-0132-0
Background
Malignant mesothelioma (MM) is an extremely aggres-
sive neoplasm linked to asbestos exposure [1]. Median
survival is very short (9–12 months), likely linked to
diagnosis at late stages of the disease. Correct patho-
logical diagnosis is of outmost importance and calretinin
has been described as one of the most sensitive and se-
lective positive markers for human MM [2, 3]. Calretinin
(CR; human gene symbol: CALB2) is a calcium-binding
protein of the EF-hand family with several reported
functions, see [4]. Together with mesothelin, the detec-
tion of CR in blood samples by ELISA has been sug-
gested as a potential predictor to detect MM at earlier
stages [5, 6]. Other discussed MM biomarkers include
soluble mesothelin-related peptides, megakaryocyte
potentiating factor, osteopontin, fibulin-3 and high
mobility group protein B1 (HMGB1) [7]. However,
the time course of appearance of these biomarkers
during human MM pathogenesis is currently un-
known. Animal models (mostly mice) are widely used
as models to address such questions.
Common genomic alterations and similar genomic
profiles, e.g. loss of tumor suppressors (NF2, LATS2,
BAP1) in murine and human MM emphasize the rele-
vance of mouse model systems to study mesothelioma-
genesis [8] and to possibly validate suggested MM
biomarkers. Such genetic mouse MM models include
mice heterozygous for NF2, one of the most often al-
tered tumor suppressor genes with up to 44% alterations
in human MM cell lines [9, 10]. Asbestos-exposed NF2+/
− mice were reported to be an important murine model
recapitulating many molecular features of human MM
and to be relevant for further investigations on MM
pathogenesis mechanisms, as well as for preclinical
testing of putative novel therapeutic approaches [11, 12].
The aim of this study was to investigate the expression
of calretinin in I) murine MM originating from NF2+/−
mice; II) MM cell lines derived from these mice and III)
murine MM cell lines from strains other than C57Bl/6J,
the genetic background of the NF2+/− mice. In addition,
to investigate any potential role for CR in murine MM
formation we assessed whether overall survival differed
between asbestos-exposed NF2+/- mice with or without a
functional Calb2 gene.
Methods
Animal studies
129S2/SvPas Nf2+/− mice (strain name: B6;129S2-
Nf2tm1Tyj/J; JAX stock #008190) were backcrossed for ≥6
generations to wild-type C57Bl/6J (C57) mice to obtain
a C57-NF2+/− mouse line. These mice were crossed with
C57-CR−/− mice [13] to give rise to the genotype C57-
NF2+/-CR−/−; animals were genotyped as described
previously [14]. Mice, 6–8 weeks of age, were injected
intraperitoneally (i.p.) with 400 μg of crocidolite
suspended in 500 μL PBS every 3 weeks for a total of eight
rounds of injection (i.e., a total of 3.2 mg of crocidolite per
mouse as described before [12]). Unio Internationale
Contra Cancrum (UICC) grade crocidolite asbestos was
obtained from SPI Supplies (West Chester, PA). For
survival analysis, mice were kept for a maximum of
33 months.
Four NOD/SCID gamma mice were injected i.p. with
a suspension (200 μl PBS) of FACS-sorted ZL55-SOhigh
cells (100,000/mouse). These genetically-modified hu-
man MM cells are identified by their increased endogen-
ous expression of the stem cell markers SOX2 and
OCT4 driving the reporter eGFP, the latter allowing for
the isolation of this small (< 5%) subpopulation [15].
ZL55-SOhigh cells show an increased tumor-initiating
capacity in vivo compared to the parental ZL55 cells.
Mice were sacrificed after 5 weeks and tissue was fixed
in 4% paraformaldehyde. Histopathological diagnosis
and analyses were performed on paraffin-embedded
samples as described before [16]. All animal experiments
were performed with the permission of the local animal
care committee (Canton of Fribourg, Switzerland) and
according to the present Swiss law and the European
Communities Council Directive 86/609/EEC.
Western Blotting
Proteins from murine MM cell lines and from C57-
NF2+/− tumor samples were prepared as described
before [16]. Briefly, protein extracts from MM cell lines
(AB12, AK7, RN5 [16], RN29) were separated by SDS-
PAGE (10% gel) and transferred onto a nitrocellulose
membrane. The membrane was incubated with primary
antibody against calretinin (rabbit polyclonal CR7696
[17]), previously available from SWANT, Marly,
Switzerland at a dilution of 1:10,000. Secondary biotinyl-
ated anti-rabbit IgG at a dilution of 1:10,000 for 2 h at
RT was used. For signal detection the ABC system
(Vectastain, Vector Laboratories, Burlingame, CA) was
applied and chemiluminescent signals were revealed with
the HRP substrate (Millipore, Luminata Forte); signals were
detected with the Western blot reader (FluorChem E
System, Bucher Biotec, Basel, Switzerland) as previ-
ously described [18].
Histological analysis
Tumor samples were fixed in 4% paraformaldehyde in PBS,
pH 7.4, dehydrated and embedded in paraffin followed by
sectioning with a microtome. Tumor samples were patho-
logically evaluated using hematoxylin/eosin or Goldner-
stained sections. For immunohistochemistry, sections were
deparaffinized and incubated in antigen-retrieval solu-
tion using sodium citrate, pH 6, and processed as
described before [19]. Primary antibodies (CR7696,
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CR7697 or CR7699/4; SWANT, Marly, Switzerland) were
used at a 1:500 dilution with overnight incubation at 4 °C.
Semi-quantitative RT-PCR of Calb2 mRNA levels
The expression of murine Calb2 mRNA was detected by
semi-quantitative RT-PCR. Murine mesothelioma cell lines
were cultured under standard conditions [16] and total
RNA extracted with PeqGold Trifast (Axonlab, Le Mont-
sur-Lausanne, Switzerland) following the manufacturer’s
protocol. cDNA was prepared from 500 ng total RNA using
the QuantiTect Reverse Transcription kit (Qiagen, Stockach,
Germany) by following manufacturer’s instructions. As
housekeeping gene the ribosomal protein 13S was used and
Calb2 expression was assessed using the following primers:
Calb2 -FW: 5′-GAA ATG GGT ACA TTG AAG GTA-3′,
Calb2 RV 5’-CCA TCT GAG TTC TTC TTA TCA TAC
5′, RPS-13 FW 5’CGA AAG CAT CTT GAG AGG AAC A
3′, RPS-13 RV 5’-TCG AGC CAA ACG GTG AAT C-3′.
Statistical analysis
GraphPad Prism version 7 and R statistical software
were used to perform the log-rank test (Mantel-Cox
test) on the Kaplan-Meier survival plot for comparison.
Results
The repetitive injection of crocidolite in C57-NF2+/-
mice resulted in approximately 10% of confirmed
murine mesothelioma cases and in a multitude of
granuloma formation in treated animals [12].
Granuloma were described to be rich in reactive
mesothelial cells and human reactive mesothelial cells
were previously shown to be strongly positive for CR
[20]. Human ZL55 MM cells injected i.p. into NOD/
SCID gamma mice were used as a positive control.
ZL55-derived tumors showed strong calretinin IHC
staining, clearly a differentiating marker for the tumor
nodules located in connective tissue often consisting of
CR-negative nodules of adipose tissue (Fig. 1a-c). None
of the C57-NF2+/− mice-derived MM cells and the react-
ive mesothelial cells on the peritoneal side of the dia-
phragm from the same mice showed CR expression in
the IHC analysis, representative examples are shown in
Fig. 1d-e. As previously described [14], the developing
lung of the murine embryo shows staining for CR in the
visceral mesothelial layer and in a fraction of mesenchy-
mal cells (Fig. 1f ), even though staining is weaker com-
pared to human mesothelioma [14]. Also in the
developing human lung, cells of the visceral pleura, i.e.
the outermost mesothelial cell layer, as well as a subpop-
ulation of stromal (mesenchymal) cells stained positive
for CR, in particular evident as brown-stained cytoplasm
in mesothelial cells in Fig. 1g (inset; arrows). Few stro-
mal cells in the mesenchyme showed very strong stain-
ing (Fig. 1g, arrowheads). Note the absence of specific
CR staining in the developing epithelial cells of the lung.
A control section stained without primary CR antibody
was negative (Fig. 1h) including the single layer of meso-
thelial cells (inset; arrows).
In order to confirm the IHC results we performed
Western blot analysis to detect CR expression in murine
MM cell lines. Even when loading ≥50 μg of protein no
specific CR signal at approximately 30 kDa was detected
in all mouse cell lines (Fig. 2a) and in immortalized meso-
thelial cells from a C57 mouse (iMeso-WT1 [16, 21]; not
shown), while a signal was evident in extracts from the
human MM cell line MSTO-211H, as well as in mouse
cerebellum, described to be rich in CR [22] (Fig. 2a). A
protein extract from isolated primary mesothelial cells of a
C57-CR−/− mouse served as negative control. Calb2 was
detected at the mRNA level in all tested murine MM cell
lines and in mesothelial iMeso-WT1 cells (Fig. 2b), but
not in mouse primary mesothelial cells maintained in cul-
ture for 24 h, the latter as reported before [14].
In human MM, calretinin is considered to be the most
sensitive and selective marker for the diagnosis, in par-
ticular of the epithelioid and the epithelioid part of the
biphasic MM type [3]. Furthermore, its essential func-
tion in vitro in human MM cell lines [18], as well as its
function in protection from asbestos-induced cytotox-
icity has been demonstrated before [23]. While the clin-
ical relevance of calretinin IHC in the diagnosis of
human MM is undisputed, the putative role of calretinin
in the development of MM in vivo has remained elusive.
Thus, mouse survival after asbestos exposure was tested
in a well-studied MM mouse model, i.e. in mice hetero-
zygous for the tumor suppressor NF2 [11] either wild-
type (C57-NF2+/−) or null-mutant (C57-NF2+/-CR−/−)
for the Calb2 gene. Long-term survival data were
analyzed by the standard Kaplan-Meyer method and
differences between groups were assessed using a log-
rank test. Mice (48 in total) of the two genotypes were
treated with asbestos (NF2+/-CR+/+, n = 18; NF2+/-CR−/−;
n = 30). A total of 17 (94%) mice (2 with diagnosed MM)
died in the NF2+/-CR+/+ group (censored, n = 1) and 28
(93%; 3 with diagnosed MM) died in the NF2+/-CR−/−
group (censored, n = 2) until the end of the long-term
follow up in the 2 cohorts. Kaplan-Meier curves were
similar in both groups. Median survival was 14.
22 months (95% confidence interval: 9.23–19.07) in mice
with a functional Calb2 gene (NF2+/-CR+/+) and 14.
63 months (95% confidence interval 13.4–17.3) in mice
with a non-functional Calb2 gene (NF2+/-CR−/−). A log-
rank test indicated no significant difference in survival
(p = 0.7345). The log-rank hazard ratio (NF2+/-CR+/+
used as reference) was 0.90 (95% confidence interval 0.
49–1.66). This indicates that mice with a functional
Calb2 gene have a marginally higher, however
insignificant, risk of death after asbestos exposure.
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Discussion
Our results indicate that MM derived from asbestos-
exposed C57-NF2+/− mice do not express calretinin
protein levels detectable by either IHC or Western blot
analysis. No positive Western blot signal was observed
in RN5 and RN29 MM cells derived from MM tissue of
the same asbestos-exposed C57-NF2+/− mouse strain;
yet, RN5 and RN29 cells express Calb2 mRNA.
Likewise, well-established murine MM cell lines AK7
[24] also from C57 mice, and AB12 cells from Balb/c
mice were negative for CR protein expression and
positive for Calb2 mRNA. Based on the previous obser-
vation of a very strong positive correlation between CR
protein and CALB2 mRNA levels in 13 human MM cell
lines, i.e. regulation mostly at the transcriptional level
(see Fig. 1c in [25]), we assume levels of Calb2 mRNA
to be low in mouse MM cell lines and MM tissue with
no detectable CR protein levels. However, species differ-
ences in CR regulation may not be entirely excluded.
Thus, in contrast to human MM, where calretinin is
considered as a positive marker, we did not detect calre-
tinin at the protein level in MM and derived cell lines of
mouse origin. Even human sarcomatoid MM cell lines
(e.g. ZL34, ONE58), as well as biphasic MM (e.g.
MSTO-211H, Mero83) show a clear and in few cases
relatively strong CR expression evidenced by Western
blot analysis [18, 25]. Our negative CR IHC results
are in contrast to previous reports showing positive
CR IHC staining in murine pleural MM samples. In
toxicology studies, Yokohira et al. reported positive
CR immunostaining of the lung surface in female A/J
mice exposed to 4-(methylnitrosamino)-1-(3-pyridyl)-
1-butanone (NNK) [26] and to potassium octatitanate
(TISMO) fibers [27]. In a later study, also mice from add-
itional strains (C3H/HeN, ICR and C57BL/6), exposed to
TISMO showed a thickening of the visceral pleura due to
mesothelial cell infiltration with part of the cells showing
strong CR immunoreactivity (Fig. 3 in [28]). The differ-
ences between previous results and the current ones with
respect to CR IHC might be several-fold. IHC results
might be related to differences in I) the materials used to
induce changes in the tunica serosa (NNK and TIMSO fi-
bers vs. crocidolite), II) the site of injection (pleura vs.
peritoneum) and III) the CR antibodies used. With respect
to strain differences, Yokohira et al. also reported positive
CR immunoreactivity in C57Bl/6 mice (Fig. 3 in [28]),
Fig. 1 Immunohistochemical analysis of human and mouse MM and embryonic mouse and human lung. ZL55-SOhigh cells were injected i.p. into
NOD/SCID gamma mice and tumor cells show strong expression of CR (b; higher magnification inset in c), arrow pointing towards a strong CR-positive
tumor nodule. The negative control (parallel section) is shown in (a). d) Representative example of a mouse MM showing absence of CR expression, as well
as in another example of an asbestos-induced lymphocytic and granulomatous inflammation (e) of the parietal pleura. f) In the developing lung of
a mouse, CR protein is already expressed in the visceral pleura at day 10 (arrows) as reported before [14]. g) Expression of CR in the mesothelial
cell layer (arrows) and in scattered stromal (mesenchymal) cells of the developing human lung (arrowheads). h) Negative control on parallel section
incubated without primary CR antibody. The inset shows CR-negative mesothelial cells (arrows) at 2-fold higher magnification. The few round lightly
brownish-stained cells are erythrocytes, where the endogenous peroxidase activity was not completely blocked. Abbreviations: A adipose tissue; T
tumor; S stroma; G granulomatous inflammation; D pleura parietalis adjacent to the diaphragm; L lung. Scale bars: A and B: 2.5 mm, C:
500 μm. D-F: 100 μm; G,H: 50 μm; insets with layer of mesothelial cells: 2-fold magnification compared to G,H
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while our tissue samples and cell lines (RN5, RN29, AK7)
derived from C57Bl/6 mice were negative for CR. Of note,
in the same study by Yokohira et al., weak CR positivity
was also detectable in the healthy lung tissue, especially in
C57Bl/6 J mice [28], while lung tissue was always com-
pletely negative in our study, in line with many studies
reporting that normal lung tissue is considered CR-
negative. In addition, the specificity of the CR antibody to
unequivocally detect mouse CR was not reported in the
previous studies, while we have additionally confirmed the
specificity of our CR antibodies by Western blotting.
A role for calretinin in the development of human
MM had been suggested based on in vitro studies.
Induced expression of SV40 early gene products augments
CR expression in the human mesothelial cell line MeT-
5A, which leads to increased resistance to asbestos-
mediated acute cytotoxicity, an effect mediated by the
AKT/PI3K pathway [23]. Inversely, down-regulation of
Fig. 3 Kaplan-Meier survival analysis. C57-NF2+/-CR+/+ (blue line; n= 18)
and C57-NF2+/-CR−/− (red line; n = 30) mice were injected with 8 ×
400 μg of crocidolite. The survival curves of the 2 groups (all mice) are
statistically not different (log-rank test, p = 0.7345)
Fig. 2 Western Blot analysis for calretinin and RT-PCR for the detection of Calb2 mRNA. a) Western blot signals (upper panel) and the corresponding
Ponceau Red-stained membrane (lower panel). As positive control, 10 ng of purified human recombinant CR was used. Sizes (molecular masses) of the
marker proteins in the right lane are (from top to bottom): 130, 100, 75 (red), 63, 48, 35, 28 (green), and 17 kDa. The specific signal for CR runs
just slightly above the green marker protein at approximately 30 kDa. In MSTO-211H cell extracts, a strong signal at the same position as
purified CR indicates the presence of CR in these cells. All mouse samples from the MM cell lines RN29, RN5 and AK7 (all from C57Bl/6 J
mice), AB12 (Balb/c) are negative, as well as the negative control prMC from a CR−/− mouse (prMC−/−). Mouse cerebellum extract (most
right) shows a strong signal for CR. b) Positive signals for Calb2 mRNA were detected in RN29, RN5, AB12, AK7 and iMeso-WT cells; no signal was
present in samples from freshly isolated C57 mouse prMC and in the negative control (H2O). RPS13 was used as housekeeping gene
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CR decreases the viability and proliferation of human MM
cells in vitro, most evident in epithelioid and biphasic cell
lines, but to a lesser extent also in MM cell lines with
prevalent sarcomatoid morphology [18]. Moreover, pri-
mary mesothelial cells from CR−/− mice are characterized
by a lower proliferation rate and are slower to close a
scratch evidenced in a 2D-wound assay compared to pri-
mary mesothelial cells from wild-type mice [14]. This
phenotype disappears, if CR is overexpressed in CR−/−
prMC. Based on these results we hypothesized to possibly
observe a genotype-dependent effect in the survival of in
vivo asbestos-exposed C57-NF2+/-CR−/− compared to
mice with a functional Calb2 gene (C57-NF2+/− mice).
However, survival of mice in both groups was not
different. Of note, in our survival analysis all mice were
included, not only the ones with a diagnosed bona
fide MM. Given the low penetrance in our model, as
reported before (≈10% in C57-NF2+/− mice [12]), i.e.
3/30 in the C57-NF2+/-CR−/− mouse group and 2/18
in the C57-NF2+/-CR+/+ mouse group in this study,
the small number of confined MM cases doesn’t
allow to directly link Calb2 genotype to MM-caused
mortality. Thus, including all mice might have
masked some subtle Calb2 genotype-dependent differ-
ences that are only observable in mice with a diag-
nosed MM. However, the deaths in both groups were
asbestos exposure-dependent, since unexposed mice
of both genotypes had a much higher median survival
(control C57-NF2+/-CR+/+ mice) of 29.13 months (95%
confidence interval: 5.80–32.93, log-rank test: p = 0.0008).
This leads to several different hypotheses. I) The heavy
asbestos exposure by direct intraperitoneal fiber injec-
tion resulting in relatively short latency for MM devel-
opment in mice (around 1 year in mice compared to
20–40 years in humans) leads to other routes of MM
formation in human and mice. This is partially sup-
ported by the observation of mostly sarcomatoid and bi-
phasic MM in mice compared to human, where the
largest number of MM cases is of the epithelioid type.
However, frequency of gene loci deletions containing
genes likely involved in MM formation were reported to
be similar in samples from human MM and asbestos-
exposed NF2+/− mice including CDKN2A, CDKN2B,
CHD5, TP53, and NF2 [8]. In contrast, 14/15 cell lines
derived from asbestos-injected mice of several mouse
strains showed homologous deletions of the CDKN2A
locus, but no chromosomal losses in either the BAP1
and NF2 regions and moreover no mutations in these 2
genes as well as in LATS2, commonly mutated in human
MM [29]; this might again hint towards species differ-
ences in the pathways leading to MM II). Although CR
expression is prevalent during both mouse [14] and hu-
man lung embryonic development (Fig. 1g, h), CR re-
appearance at levels detectable by Western blot analysis
selectively in human MM might point towards different
(possibly none) functions in the process of murine
mesotheliomagenesis compared to the formation of MM
in humans. Of note, the presumed role of CR in human
MM development is currently based on in vitro studies
with human MM cell lines. III) The low CR levels con-
ceivably present in mouse MM (below the detection
limit of IHC or Western blot analysis used in this study)
still might be sufficient to exert a role, e.g. as a signaling
molecule during mouse MM development. IV) Various
Calb2 mRNA transcripts, in part derived from alterna-
tive splicing (so far detected only in human MM), might
have a function on their own as recently proposed [30]
and thus Calb2 transcripts might possibly be implicated
in murine MM tumorigenesis. All of the above points
need to be considered, when using mouse MM models
with the aim to possibly find strategies that might be
applied for developing novel human therapeutic ap-
proaches. This is particularly the case when using mouse
models aimed at exploiting the putative role of CR in
the pathogenesis of human MM. In such a case, xeno-
graft models with human CR-positive MM cells might
be considered as the current method of choice. With
respect to validating CR as a biomarker for early de-
tection of human MM (currently less than 5% are di-
agnosed at an early stage 1A [31]), one needs to be
aware that CR is unlikely of any predictive value in
mouse MM models. Even if CR is expressed at very
low protein levels in mouse MM, CR plasma levels
are most probably below the detection limit of even
most sensitive ELISA techniques.
Conclusions
Our results indicate the absence of CR (at least below
the threshold of Western blot detection) in mouse MM
cell lines, in line with negative IHC staining in asbestos-
induced mouse MM tissue. These findings essentially
rule out the use of CR as a putative biomarker for early
detection of MM in mouse models, while this may well
be appropriate for human MM. Together with other di-
vergent results in human and mouse MM, e.g. with re-
spect of MM histotype or commonly mutated genes,
it requires careful consideration, when translating find-
ings obtained in one species to another.
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